MODULATION VON SRPX2-VERMITTELTER ANGIOGENESE

Patent europeic · EP2257299 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP2257299
Numer da la dumonda
EP09718390
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
03-03-2009
Publitgà
08-12-2010
Concedì
25-07-2018
Stritgà
31-03-2020
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/713 (2006.01)
C07K 14/435 (2006.01)
C12N 15/11 (2006.01)
A61K 39/395 (2006.01)
Prioritad
US 34786 P 07.03.2008
Dumonda PCT
PCT/US2009/035831 03.03.2009
Publicaziun PCT
WO2009/111444 11.09.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 21-10-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 21.10.2020

  2. 05-10-2018

    Represchentant inscrit

    Representative
    VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, Nadelberg 3, 4051 Basel

    Published in Swissreg on 05.10.2018

  3. 25-07-2018

    Concedì

    Published in Swissreg on 25.07.2018

Partidas

Possessur

Research Development Foundation

402 North Division Street, Carson City, NV 89703, US

Represchentant

Vossius & Partner Patentanwälte Rechtsanwälte mbB

VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB

Nadelberg 3, 4051 Basel

Inventur

IMHOF, Beat, A.

CH-1211 Geneva 4

MILJKOVIC-LICINA, Marijana

CH-1211 Geneva 4

HAMMEL, Philippe

CH-1211 Geneva 4

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.